Fentanyl Dealer Sentenced to Eight Years in Overdose Death
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Fentanyl Dealer Sentenced to Eight Years in Overdose Death

Fentanyl Dealer Sentenced to Eight Years in Overdose Death

April 06, 2022
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Akilah Johnson
Phone Number: (415) 436-7994

SAN JOSE, Calif. – Xavier Robledo was sentenced in federal court today to 96 months in prison for distributing fentanyl that caused overdoses in two people and killed one, announced Drug Enforcement Administration (DEA) Special Agent in Charge Wade R. Shannon and United States Attorney Stephanie M. Hinds.  The sentence was handed down by United States District Judge Beth L. Freeman.

“The death and destruction caused by fentanyl knows no boundaries. From coast to coast this poison is devastating families,” said DEA Special Agent in Charge Wade R. Shannon. “Holding accountable those, like Robledo, who ruin lives with their criminal actions is our priority.”

“M30 pills sold on the street are often laced with fentanyl, a cheap and deadly substitute,” said U.S. Attorney Stephanie M. Hinds.  “These counterfeit pills mimic oxycodone, but they can be killers in disguise.  The mismeasurement of even a microgram of fentanyl can have lethal consequences.  We urge all to stay away from fentanyl sold on the street in any form it takes.”

Robledo, 21, of Seaside in Monterey County, California, pleaded guilty on February 8, 2022, to two counts of distributing fentanyl. In his plea agreement, Robledo admitted that in mid-April 2020, Robledo sold counterfeit, fentanyl-laced pills known as “M30” pills.  M30 pills are light blue and imprinted with an “M” on one side and “30” on the other.  He arranged the sale of three fentanyl-laced M30 pills via cell phone messages to a customer to whom Robledo had previously sold M30s.  This person is identified only as “Individual 1” in the plea agreement.  Robledo admitted he personally delivered the M30 pills, which he knew contained fentanyl, to Individual 1 at his house.  The M30 pills caused Individual 1 to suffer a fentanyl overdose, and law enforcement officers found Individual 1 in an unresponsive state.  Individual 1 was later able to recover from his overdose.

Robledo further admitted in his plea agreement that in early May 2020, he again sold a counterfeit M30 that he knew contained fentanyl.  He sold this M30 to a different individual identified in the plea agreement as “Individual 2.”  Robledo knew Individual 2 because two weeks earlier Robledo sold and delivered drugs to Individual 2 at a drug rehabilitation facility where Robledo knew Individual 2 was undergoing treatment.  In the early May sale, Robledo arranged the sale to Individual 2 using cell phone messages, and Robledo delivered the M30 to Individual 2 at his house.  A few hours later Individual 2 ingested the M30 pill.  It caused him to overdose on fentanyl.  Law enforcement officers found Individual 2 in an unresponsive state and transported him to a hospital.  Individual 2 continued to be unresponsive.  On or about May 8, 2020, Individual 2 died.  Robledo admitted in his plea agreement that Individual 2 died as a result of the fentanyl in the M30 that Robledo sold him. 

In addition to the 96 month prison term, U.S. District Judge Beth L. Freeman ordered Robledo to pay restitution for, among other things, the funeral costs of Individual 2.  In addition, Robledo was sentenced to serve three years of supervised release following release from federal prison.

Assistant U.S. Attorneys Christina Liu and Casey Boome prosecuted the case with the assistance of Linda Love and Mark DiCenzo.  The prosecution is the result of an investigation by DEA and the Pacific Grove Police Department.

Fentanyl, a Schedule II controlled substance, is a highly potent opiate that can be diluted with cutting agents to create counterfeit pills that purport to mimic the effects of oxycodone and can typically be obtained at a lower cost than genuine oxycodone.  However, small variations in the amount or quality of fentanyl can have significant effects on the potency of the counterfeit pills, raising the danger of overdoses.  Fentanyl has become the leading cause of drug overdose deaths in the United States.  In this case, the counterfeit, fentanyl-laced pills that Robledo distributed were shaped and colored to resemble oxycodone pills that are sold legitimately in the marketplace. As in this case, counterfeit pills known as M30s are round tablets that are sometimes light blue and with “M” and “30” imprinted on opposite sides of the pill.

This prosecution is part of an Organized Crime Drug Enforcement Task Forces (OCDETF) investigation. OCDETF identifies, disrupts, and dismantles the highest-level drug traffickers, money launderers, gangs, and transnational criminal organizations that threaten the United States by using a prosecutor-led, intelligence-driven, multi-agency approach that leverages the strengths of federal, state, and local law enforcement agencies against criminal networks.

                                                                                                       ###

                                                                                                                 

Download Press Release
###
Fentanyl
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Bob P. Beris, Special Agent in Charge - San Francisco
@DEASanFrancisco
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster